Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset Development
March 22 2023 - 6:30AM
Syneos Health® (Nasdaq:SYNH), a leading fully integrated
biopharmaceutical solutions organization, today announced a
strategic partnership with KX, maker of kdb, the world’s fastest
time series database and analytics engine. The partnership will
deliver data-driven predictive analytics, Artificial Intelligence
(AI) and Machine Learning (ML) capabilities to help customers
address complex healthcare decisions via the industry's first Data
Timehouse, a new class of data and AI management engine designed
for temporal data generated by digital transformation. Benefits
include real-time engagement and faster and more accurate
decision-making related to drug trial site selection.
Through the collaboration, Syneos Health and KX will improve
clinical trial efficiency, reduce costs and speed time to market
for life-changing therapies for patients. The partnership will
empower biopharmaceutical customers to better solve complex
healthcare decisions through data – meeting them wherever they are,
and supporting their needs, across the clinical to commercial
continuum.
“Our KX partnership advances our ability to deliver data-driven
insights and AI-enabled solutions, helping biopharma customers
solve their most complex clinical development and commercialization
challenges,” said Baba Shetty, President, Technology and Data
Solutions, Syneos Health. “We’ve seen first-hand with multiple
customers the ability of KX to dramatically accelerate the most
challenging computational challenges with massive data sets,
supporting use cases including patient simulations (QSP) for
clinical and omnichannel/Real World Evidence for commercial.”
Earlier this week, Syneos Health announced a strategic
partnership with Microsoft to accelerate AI across the clinical to
commercial continuum. The company’s collaboration with KX amplifies
this work as both parties utilize Microsoft’s Azure technology to
bring the potential benefits of AI, ML and tech-enabled solutions
to customers, providing them with data-driven insights that will
enhance performance, effectiveness and efficiency across the asset
development lifecycle.
“Our work with Syneos Health is a game-changer for the industry.
Together, we’re unblocking data access and computing challenges,
compressing both the timeframes and costs associated with
delivering answers to some of the world’s most important and
demanding healthcare questions,” said Ashok Reddy, CEO at KX.
“Delivering up to one hundred times faster performance at one-tenth
the cost of alternative solutions, our Data Timehouse leverages the
power of data analytics and AI to enable faster execution of
clinical trials and discovery of new drug treatments, ultimately
increasing the likelihood of any given trial’s success. We’re proud
to partner with Syneos Health on this revolutionary journey.”
Syneos Health’s technology and data efforts seek to enhance
customers’ asset value, with the goal of delivering clinical,
medical affairs and commercial solutions informed by
industry-leading predictive insights to help unlock efficiencies,
accelerate timelines and optimize resource allocation.
About Syneos Health Syneos Health®
(Nasdaq:SYNH) is a leading fully integrated biopharmaceutical
solutions organization built to accelerate customer success. We
translate unique clinical, medical affairs and commercial insights
into outcomes to address modern market realities.
We bring together a talented team of professionals, who work
across more than 110 countries, with a deep understanding of
patient and physician behaviors and market dynamics. Together
we share insights, use the latest technologies and apply advanced
business practices to speed our customers’ delivery of important
therapies to patients.
Syneos Health supports a diverse, equitable and inclusive
culture that cares for colleagues, customers, patients, communities
and the environment.
To learn more about how we are Shortening the distance
from lab to life®, visit syneoshealth.com
or subscribe to our podcast.
About KXOur mission is to accelerate the speed
of data and AI-driven business innovation enabling customers to
transform into real-time, intelligent enterprises. Built for the
most demanding data environments, our Data Timehouse software is
trusted by the world’s top investment banks and hedge funds, and
leading companies in the life and health sciences, semiconductor,
telecommunications, and manufacturing industries.
At the heart of our technology is the kdb time series database
and analytics engine, independently benchmarked as the fastest on
the market. It can process and analyze time series and historical
data at unmatched speed and scale, empowering developers, data
scientists, and data engineers to build high-performance
data-driven applications and turbo-charge their favorite analytics
tools in the cloud, on-premise, or at the edge.
Ultimately, our technology enables the discovery of richer,
actionable insights for faster, more accurate decision-making which
drives competitive advantage and transformative growth for our
customers.
KX operates from more than 15 offices across North America,
Europe and Asia Pacific. For more information visit www.kx.com or
contact: pr@kx.com
Contacts: |
|
|
Syneos Health Investor Relations: |
|
Syneos Health Press/Media: |
Ronnie Speight |
|
Gary Gatyas |
Senior Vice President, Investor Relations |
|
Executive Director, External Communications |
+1 919 745 2745 |
|
+1 908 763 3428 |
Investor.Relations@syneoshealth.com |
|
gary.gatyas@syneoshealth.com |
KX Press/Media:Paul WoodingVice President,
Corporate Communications+ 44 7540 437 282pwooding@kx.com
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jul 2023 to Jul 2024